These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 2177997

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ispaghula husk in the treatment of hypercholesterolaemia: a double-blind controlled study.
    MacMahon M, Carless J.
    J Cardiovasc Risk; 1998 Jun; 5(3):167-72. PubMed ID: 10201553
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
    Lee KJ, Kim NY, Kwon JK, Huh KC, Lee OY, Lee JS, Choi SC, Sohn CI, Myung SJ, Park HJ, Choi MK, Bak YT, Rhee PL.
    Neurogastroenterol Motil; 2011 Dec; 23(12):1098-104. PubMed ID: 21920001
    [Abstract] [Full Text] [Related]

  • 4. Comparison of two different formulations of mebeverine hydrochloride in irritable bowel syndrome.
    Gilbody JS, Fletcher CP, Hughes IW, Kidman SP.
    Int J Clin Pract; 2000 Sep; 54(7):461-4. PubMed ID: 11070572
    [Abstract] [Full Text] [Related]

  • 5. A double-blind placebo-controlled crossover study of mebeverine and mefenamic acid in the treatment of primary dysmenorrhoea.
    Langrick AF, Gunn AD, Livesey H, Whitehead AM.
    Br J Clin Pract; 1989 Sep; 43(9):317-21. PubMed ID: 2620043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients.
    Jones RH, Holtmann G, Rodrigo L, Ehsanullah RS, Crompton PM, Jacques LA, Mills JG.
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1419-27. PubMed ID: 10571597
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term treatment of irritable bowel syndrome: results of a randomized controlled trial.
    Misra SP, Thorat VK, Sachdev GK, Anand BS.
    Q J Med; 1989 Oct; 73(270):931-9. PubMed ID: 2697886
    [Abstract] [Full Text] [Related]

  • 14. Comparison of various treatments for irritable bowel syndrome.
    Ritchie JA, Truelove SC.
    Br Med J; 1980 Nov 15; 281(6251):1317-9. PubMed ID: 6254602
    [Abstract] [Full Text] [Related]

  • 15. A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome.
    Van Outryve M, Mayeur S, Meeus MA, Rosillon D, Hendrickx B, Ceuppens M.
    J Clin Pharm Ther; 1995 Oct 15; 20(5):277-82. PubMed ID: 8576295
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr 15; 18(100):75-9. PubMed ID: 19585728
    [Abstract] [Full Text] [Related]

  • 18. An open, randomised, parallel group study of lactulose versus ispaghula in the treatment of chronic constipation in adults.
    Rouse M, Chapman N, Mahapatra M, Grillage M, Atkinson SN, Prescott P.
    Br J Clin Pract; 1991 Apr 15; 45(1):28-30. PubMed ID: 1931536
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and safety of trimebutine versus mebeverine in the treatment of irritable bowel syndrome.
    Rahman MZ, Ahmed DS, Mahmuduzzaman M, Rahman MA, Chowdhury MS, Barua R, Ishaque SM.
    Mymensingh Med J; 2014 Jan 15; 23(1):105-13. PubMed ID: 24584382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.